Insulin Inhaler: New Diabetes Option Before Meals
There’s good news for patients who would like an easier way to get their insulin. A new rapid inhaled insulin has been approved by the Food and Drug Administration (FDA).
The new drug, called Afrezza®, delivers insulin in the form of a fine powder, and you can inhale it at the start of a meal to help with blood sugar control.
As a nurse and certified diabetes educator who has also lived with diabetes for the past 17 years, I wanted to try this new option. After using it for a few months, I found the inhaled insulin to be effective, easy to use, and a great alternative to an injection when I needed mealtime insulin. It can be used safely with any basal insulin, such as Lantus®, Levemir® or Toujeo®. Anyone who has Type 1 or Type 2 diabetes can benefit from this treatment option.
Here are some of the benefits of the inhaled insulin:
It decreases risk for hypoglycemia. The onset time is 12 to 15 minutes and it is totally out of your system within 180 minutes.
It is painless, convenient and effective. Once inhaled, the insulin gets released into the body through your lungs and released into tiny airways that help move the insulin into the bloodstream quickly.
Color coding makes the dosages easy to identify. The color coding of the blisters are blue for four units, green for eight units and yellow for 12 units of insulin. This color coding decreases the possibility of errors.
The blister and the inhaling device are small and compact. Both can easily fit into a small purse or pant pocket.
The inhaling device is included with the monthly prescription. The dev Continue reading